Astellas Announces FDA Listing of DIGITIVA™ for the Management of Heart Failure
Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced that DIGITIVA™, a non-invasive digital health solution for heart failure management, has been listed with ...
Stockhead on MSN20m
Break it Down: Paradigm Biopharmaceuticals en route to Phase 3 clinical trial with FDA support
Stockhead TV's Sarah Hughan brings you today's Break it Down, detailing the US Government support for Paradigm ...
RFK Jr. says he’s helping Trump pick leaders of FDA, NIH, CDC
Former independent presidential candidate and anti-vaccine advocate Robert F. Kennedy Jr. said that former President Trump ...
ICU Medical recalls tubes used in tracheostomy due to manufacturing defect
Specific lots of the tubes sold under the Bivona brand by ICU's unit Smiths Medical for neonatal or pediatric and adult patients are being recalled due to a manufacturing defect that may cause the ...
The Globe and Mail1h
Healthcare Shares Pop On FDA Clearance
What a session it was for a certain Colorado-based healthcare company after it was announced that it received the US Food and ...